Phase i studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia

1. Lapusan, S.
2. Vidriales, M.B.
3. Thomas, X.
4. De Botton, S.
5. Vekhoff, A.
6. Tang, R.
7. Dumontet, C.
8. Morariu-Zamfir, R.
9. Lambert, J.M.
10. Ozoux, M.-L.
11. Poncelet, P.
12. San Miguel, J.F.
13. Legrand, O.
14. DeAngelo, D.J.
15. Giles, F.J.
16. Marie, J.-P.